The Netherlands
FlowView Diagnostics is an innovative player in the intersection of Health Care and Information Technology, established in 2020 and headquartered in The Netherlands. The company specializes in AI-powered flow cytometry solutions, offering the Asudes platform, which utilizes the patented Eclipse algorithm to automate complex data analysis in healthcare.
As a pioneering entity, FlowView Diagnostics aims to make flow cytometry analysis both accessible and actionable for its target users, including healthcare professionals and Clinical Research Organizations (CROs). Through automation, the company enhances data consistency and visualization, providing assurance and efficiency in complex medical assessments.
The company secured a €2.70M Seed Round investment on 24 June 2022, backed by investor Amatis. This infusion of capital underscores the confidence in FlowView Diagnostics as a forward-thinking enterprise capable of advancing AI applications in medical data analysis.
